mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.048 |
0.3 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.3 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.3 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.3 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.3 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |